首页> 美国政府科技报告 >Guidance for Industry and FDA Staff: Dear Health Care Provider Letters: Improving Communication of Important Safety Information.

【24h】

Guidance for Industry and FDA Staff: Dear Health Care Provider Letters: Improving Communication of Important Safety Information.

机译：工业和FDa工作人员指南：亲爱的医疗服务提供者信函：改善重要安全信息的沟通。

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2014
页码 1-20
总页数 20
原文格式 PDF
正文语种 eng
中图分类
关键词
Public health; Health care facilities; Information letters; Physicians; Correspondence; Drug products; Prescriptions; Evaluations; Dear Health Care Provider(DHCP) letters;

机译：公共卫生;医疗保健设施;信息信;医生;通信;药品;处方;评估;亲爱的医疗服务提供者（DHCp）信函;

相似文献

外文文献
中文文献
专利

1. New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval New Drug/Biologies License Applications Filed by Manufacturer Significant Labeling Changes or "Dear Health Care Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2009,第12期

机译：由FDA批准的新药由FDA批准的FDA代理人批准的新剂型和适应症由制造商提交的与安全有关的重要标签更改或“亲爱的医疗保健专业人员”申请的新药/生物许可申请
2. New Dosage Forms and Indications Approved by the FDA Agents Pending FDA ApprovalSignificant Labeling Changes or "Dear Health Care Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2009,第5期

机译：待FDA批准前FDA代理商批准的新剂型和适应症与安全相关的重要标签更改或“尊敬的医疗保健专业人员”字母
3. New Drugs Approved by the FDANew Dosage Forms and Indications Approved by the FDAAgents Pending FDA ApprovalNew Drug/Biologies License Applications Filedby ManufacturerSignificant Labeling Changes or "Dear Health Care Professional" Letters Related to Safety [J] . Danial E. Hospital pharmacy. . 2009,第11期

机译：FDA批准的新药FDA批准的FDA代理商批准的新剂型和适应症制造商提交的新药/生物许可申请与安全相关的重要标签更改或“亲爱的医疗保健专业人员”信
4. An intelligent performance assessment system for enhancing the service quality of home care nursing staff in the healthcare industry [C] . Valerie Tang, K.L. Choy, Paul K.Y. Siu, Portland International Conference on Management of Engineering and Technology . 2016

机译：智能绩效评估系统，可提高医疗保健行业中家庭护理人员的服务质量
5. Understanding the Role of Communication between Healthcare Providers and Nonhealthcare Providers in Liberia's Fragile Healthcare System [D] . Tatus, Augustine S. 2017

机译：了解利比里亚脆弱的医疗保健系统中医疗保健提供者与非医疗保健提供者之间的沟通作用
6. Women and Their Health Care Providers: A Matter of Communication: Improving communication between women and health care providers [O] . Paul G. Rogers 1987

机译：妇女及其医疗保健提供者：沟通事项：改善妇女与医疗保健提供者之间的沟通
7. FDA’s New Guidance for Industry Addressing Evaluation of the Safety of New Drugs for Improving Glycemic Control: A Case Study in Regulatory Science [O] . J. Rick Turner 2020

机译：FDA对行业的新指导，了解改善血糖控制的新药安全性的评估：监管科学的案例研究
8. Guidance for Industry and FDA Staff: Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data. [R] . 2013

机译：工业和FDa工作人员指南：使用电子医疗数据进行和报告药物流行病学安全性研究的最佳实践。

Guidance for Industry and FDA Staff: Dear Health Care Provider Letters: Improving Communication of Important Safety Information.

著录项

相似文献

相关主题

期刊订阅